Company registration number 15764799 (England and Wales)
NEUROHARMONICS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2025
PAGES FOR FILING WITH REGISTRAR
NEUROHARMONICS LTD
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 7
NEUROHARMONICS LTD
BALANCE SHEET
AS AT 30 JUNE 2025
30 June 2025
- 1 -
2025
Notes
£
£
Fixed assets
Intangible assets
5
27,220
Tangible assets
6
16,004
43,224
Current assets
Debtors
7
71,287
Cash at bank and in hand
1,170,195
1,241,482
Creditors: amounts falling due within one year
8
(21,462)
Net current assets
1,220,020
Net assets
1,263,244
Capital and reserves
Called up share capital
9
14
Share premium account
1,635,004
Profit and loss reserves
(371,774)
Total equity
1,263,244

For the financial period ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 4 March 2026 and are signed on its behalf by:
Dr B E Treeby
Director
Company registration number 15764799 (England and Wales)
NEUROHARMONICS LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 30 JUNE 2025
- 2 -
Share capital
Share premium account
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 6 June 2024
-
-
-
-
Period ended 30 June 2025:
Loss and total comprehensive income
-
-
(371,774)
(371,774)
Issue of share capital
9
14
1,635,004
-
1,635,018
Balance at 30 June 2025
14
1,635,004
(371,774)
1,263,244
NEUROHARMONICS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2025
- 3 -
1
Accounting policies
Company information

Neuroharmonics Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Research and development expenditure

Research and development expenditure is written off against profits in the year in which it is incurred.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
10 years straight line
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
3 years straight line
Computers
3 years straight line
1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

NEUROHARMONICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
1
Accounting policies
(Continued)
- 4 -
1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash at bank only.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include other debtors and corporation tax repayable are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade creditors, taxation & social security and other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.

NEUROHARMONICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
1
Accounting policies
(Continued)
- 5 -
1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
Number
Total
5
4
Directors' remuneration
2025
£
Remuneration paid to directors
187,213
NEUROHARMONICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
- 6 -
5
Intangible fixed assets
Patents & licences
£
Cost
At 6 June 2024
-
0
Additions
27,220
At 30 June 2025
27,220
Amortisation and impairment
At 6 June 2024 and 30 June 2025
-
0
Carrying amount
At 30 June 2025
27,220
6
Tangible fixed assets
Plant and machinery etc
£
Cost
At 6 June 2024
-
0
Additions
18,178
At 30 June 2025
18,178
Depreciation and impairment
At 6 June 2024
-
0
Depreciation charged in the period
2,174
At 30 June 2025
2,174
Carrying amount
At 30 June 2025
16,004
7
Debtors
2025
Amounts falling due within one year:
£
Corporation tax recoverable
46,925
Other debtors
24,362
71,287
NEUROHARMONICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
- 7 -
8
Creditors: amounts falling due within one year
2025
£
Trade creditors
5,524
Taxation and social security
8,760
Other creditors
7,178
21,462
9
Called up share capital
2025
2025
Ordinary share capital
Number
£
Issued and not fully paid
Ordinary of 0.001p each
966,898
10
2025
2025
Preference share capital
Number
£
Issued and fully paid
Preferred of 0.001p each
358,636
4
Preference shares classified as equity
4
Total equity share capital
14

On incorporation 9 Ordinary £1 shares were issued at par. These remain unpaid and are included in debtors.

On 18 December 2024, the Ordinary £1 shares were sub-divided into 900,000 0.001p shares.
On 20 December, the company issued 66,898 Ordinary 0.001p shares for a total consideration of £25,007, and 358,636 Preferred 0.001p shares for a total consideration of £1,610,002.

10
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
£
Total commitments
32,720
2025-06-30 2024-06-06 false false false 04 March 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity M J Roberts Mr T D Boer M D Brown Mr A Stanziola B E Treeby 15764799 2024-06-06 2025-06-30 15764799 2025-06-30 15764799 core:PatentsTrademarksLicencesConcessionsSimilar 2025-06-30 15764799 core:OtherPropertyPlantEquipment 2025-06-30 15764799 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 15764799 core:CurrentFinancialInstruments 2025-06-30 15764799 core:ShareCapital 2025-06-30 15764799 core:SharePremium 2025-06-30 15764799 core:RetainedEarningsAccumulatedLosses 2025-06-30 15764799 core:ShareCapitalOrdinaryShareClass1 2025-06-30 15764799 core:ShareCapitalPreferenceShareClass1 2025-06-30 15764799 bus:Director5 2024-06-06 2025-06-30 15764799 core:RetainedEarningsAccumulatedLosses 2024-06-06 2025-06-30 15764799 core:ShareCapital 2024-06-06 2025-06-30 15764799 core:SharePremium 2024-06-06 2025-06-30 15764799 core:IntangibleAssetsOtherThanGoodwill 2024-06-06 2025-06-30 15764799 core:PatentsTrademarksLicencesConcessionsSimilar 2024-06-06 2025-06-30 15764799 core:FurnitureFittings 2024-06-06 2025-06-30 15764799 core:ComputerEquipment 2024-06-06 2025-06-30 15764799 core:PatentsTrademarksLicencesConcessionsSimilar 2024-06-05 15764799 core:PatentsTrademarksLicencesConcessionsSimilar core:ExternallyAcquiredIntangibleAssets 2024-06-06 2025-06-30 15764799 core:OtherPropertyPlantEquipment 2024-06-05 15764799 core:OtherPropertyPlantEquipment 2024-06-06 2025-06-30 15764799 bus:OrdinaryShareClass1 2024-06-06 2025-06-30 15764799 bus:PreferenceShareClass1 2024-06-06 2025-06-30 15764799 bus:OrdinaryShareClass1 2025-06-30 15764799 bus:PreferenceShareClass1 2025-06-30 15764799 bus:PrivateLimitedCompanyLtd 2024-06-06 2025-06-30 15764799 bus:SmallCompaniesRegimeForAccounts 2024-06-06 2025-06-30 15764799 bus:FRS102 2024-06-06 2025-06-30 15764799 bus:AuditExemptWithAccountantsReport 2024-06-06 2025-06-30 15764799 bus:Director1 2024-06-06 2025-06-30 15764799 bus:Director2 2024-06-06 2025-06-30 15764799 bus:Director3 2024-06-06 2025-06-30 15764799 bus:Director4 2024-06-06 2025-06-30 15764799 bus:FullAccounts 2024-06-06 2025-06-30 xbrli:pure xbrli:shares iso4217:GBP